Trial intelligence / Profile preview

Furosemide for Bladder Filling in Pediatric Ovarian Torsion

NCT05098366Phase 1Completed

Sponsor
Connecticut Children's Medical Center
Start
May 2021
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of furosemide (2 arms), sponsored by Connecticut Children's Medical Center. Primary endpoint: Time from initiation of intervention to large, ovoid bladder on POCUS at 3 hours. Started May 2021; status: completed.

02

Drugs

furosemide

Beyond the preview

Go deeper on NCT05098366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05098366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call